Controlling epidemic viral infection

Current Opinion in Infectious Diseases

Volumn 24, Issue 2, 2011, Pages 130-136

  Waterer, Grant ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

control; epidemic; H1N1; pandemic; SARS; viral

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ARTICLE; ASYMPTOMATIC INFECTION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIC; HAND WASHING; HEALTH EDUCATION; HUMAN; INFLUENZA A (H5N1); MORTALITY; PATIENT CARE; PHENOTYPE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRULENCE; VIRUS INFECTION; VIRUS STRAIN; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; SENTINEL SURVEILLANCE; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 79952192540     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328343b720     Document Type: Article

References (85)

1. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-1976. (Pubitemid 36569985)
2. Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005; 310:676-679. (Pubitemid 41528160)
3. Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 2003; 111:1605-1609. (Pubitemid 38057739)
4. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
5. Skountzou I, Koutsonanos DG, Kim JH, et al. Immunity to pre1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J Immunol 2010; 185:1642-1649.
6. Lemaitre M, Leruez-Ville M, De Lamballerie XN, et al. Seasonal H1N1 2007 influenza virus infection is associated with elevated preexposure antibody titers to the 2009 pandemic influenza A (H1N1) virus. Clin Microbiol Infect 2010 [Epub ahead of print].
7. Caley P, Becker NG, Philp DJ. The waiting time for inter-country spread of pandemic influenza. PLoS One 2007; 2:e143.
8. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003; 349:2431-2441. (Pubitemid 37542993)
9. Chan LH, Lee PK, Chan G. China engages global health governance: processes and dilemmas. Glob Public Health 2009; 4:1-30.
10. Liu Y. China's public health-care system: facing the challenges. Bull World Health Organ 2004; 82:532-538. (Pubitemid 38969447)
11. Liang H, Xue Y. Investigating public health emergency response information system initiatives in China. Int J Med Inform 2004; 73:675-685. (Pubitemid 39119621)
12. World Health Organisation. International health regulations (2005). 2nd ed. [Organisation WH (Series Editor)] 2008.
13. Kamradt-Scott A. The evolving WHO: implications for global health security. Glob Public Health 2010; 1-13.
14. Rajagopal S, Treanor J. Pandemic (avian) influenza. Semin Respir Crit Care Med 2007; 28:159-170. (Pubitemid 46676910)
15. Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet 2006; 368:886-889. (Pubitemid 44292808)
16. Ginsberg M, Hopkins J, Maroufi A, et al. Swine influenza A (H1N1) infection in two children-southern Califorina. Morbid Mortal Wkly Rep 2009; 58: 1-2.
17. World Health Organisation. Global alert and response: influenza-like illness in the United States and Mexico. 2009.
18. Fidler DP. H1N1 after action review: learning from the unexpected, the success and the fear. Future Microbiol 2009; 4:767-769. A very nice commentary on the politics of H1N1 09 and WHO.
19. Wilson K, Brownstein JS, Fidler DP. Strengthening the International Health Regulations: lessons from the H1N1 pandemic. Health Policy Plan 2010; 25:505-509.
20. Bell DM. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006; 12:81-87.
21. Bell DM. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006; 12:88-94.
22. World Health Organization. Hospital infection control guidance for severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/infection control/en/2003 [accessed 3 June 2007].
23. Martin R, Conseil A, Longstaff A, et al. Pandemic influenza control in Europe and the constraints resulting from incoherent public health laws. BMC Public Health 2010; 10:532.
24. St John RK, King A, de Jong D, et al. Border screening for SARS. Emerg Infect Dis 2005; 11:6-10. (Pubitemid 40093345)
25. Bitar D, Goubar A, Desenclos JC. International travels and fever screening during epidemics: a literature review on the effectiveness and potential use of noncontact infrared thermometers. Euro Surveill 2009; 14.
26. Mukherjee P, Lim PL, Chow A, et al. Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore. Emerg Infect Dis 2010; 16:21-26.
27. World Health Organisation. Severe acute respiratory syndrome (SARS). Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/country/table2004- 04-21/en/ [accessed 22 October 2010].
28. Australian Department of Health and Aging. New pandemic phase protect. http://www.healthemergency.gov.au/internet/healthemergency/publishing. nsf/Content/news-170609 [accessed 22 October 2010].
29. Cowling BJ, Ng DM, Ip DK, et al. Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. J Infect Dis 2010; 202:867-876.
30. Jones JH, Salathe M. Early assessment of anxiety and behavioral response to novel swine-origin influenza A(H1N1). PLoS One 2009; 4: e8032.
31. Fowler RA, Lapinsky SE, Hallett D, et al. Critically ill patients with severe acute respiratory syndrome. J Am Med Assoc 2003; 290:367-373. (Pubitemid 37430523)
32. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. J Am Med Assoc 2003; 290:374-380. (Pubitemid 37430524)
33. Heung LC, Li T, Mak SK, Chan WM. Prevalence of subclinical infection and transmission of severe acute respiratory syndrome (SARS) in a residential care home for the elderly. Hong Kong Med J 2006; 12:201-207. (Pubitemid 43925934)
34. Yang Z, Wang S, Li Q, et al. Determining SARS sub-clinical infection: a longitudinal seroepidemiological study in recovered SARS patients and controls after an outbreak in a general hospital. Scand J Infect Dis 2009; 41:507-510.
35. Lee VJ, Yap J, Tay JK, et al. Seroconversion and asymptomatic infections during oseltamivir prophylaxis against influenza A H1N1 2009. BMC Infect Dis 2010; 10:164.
36. Yang Y, Sugimoto JD, Halloran ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326:729-733.
37. Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009; 325:484-487.
38. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003; 300:1961-1966. (Pubitemid 36734606)
39. Wynia MK. Ethics and public health emergencies: restrictions on liberty. Am J Bioeth 2007; 7:1-5. (Pubitemid 46364809)
40. Lo B, Katz MH. Clinical decision making during public health emergencies: ethical considerations. Ann Intern Med 2005; 143:493-498. (Pubitemid 41377199)
41. Torda A. Ethical issues in pandemic planning. Med J Aust 2006; 185:S73-S76. (Pubitemid 44823413)
42. Tarantola D, Amon J, Zwi A, et al. H1N1, public health security, bioethics, and human rights. Lancet 2009; 373:2107-2108.
43. Webster CH. Airline operating realities and the global spread of infectious diseases. Asia Pac J Public Health 2010; 22:137S-143S.
44. Malone JD, Brigantic R, Muller GA, et al. U.S. airport entry screening in response to pandemic influenza: modeling and analysis. Travel Med Infect Dis 2009; 7:181-191.
45. Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses: New Zealand, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:918-921.
46. Wagner BG, Coburn BJ, Blower S. Calculating the potential for within-flight transmission of influenza A (H1N1). BMC Med 2009; 7:81.
47. Baker MG, Thornley CN, Mills C, et al. Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study. Br Med J 2010; 340:c2424.
48. Olsen SJ, Chang HL, Cheung TY, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 2003; 349:2416-2422. (Pubitemid 37542990)
49. Hadler JL, Konty K, McVeigh KH, et al. Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May-June 2009. PLoS One 2010; 5:e11677.
50. Jefferson T, Doshi P.WHOand pandemic flu. Time for change, WHO. Br Med J 2010; 340:c3461.
51. Watson R.WHOis accused of 'crying wolf' over swine flu pandemic. Br Med J 2010; 340:c1904.
52. O'Dowd A. Council of Europe condemns 'unjustified scare' over swine flu. Br Med J 2010; 340:c3033.
53. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. J Am Med Assoc 2009; 302:1880-1887.
54. Muscatello DJ, Cretikos MA, Macintyre CR. All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009. Emerg Infect Dis 2010; 16:1396-1402.
55. Nishiura H. The virulence of pandemic influenza A (H1N1) 2009: an epidemiological perspective on the case-fatality ratio. Expert Rev Respir Med 2010; 4:329-338.
56. Update. Influenza activity: United States 2009-10 season. MMWR Morb Mortal Wkly Rep. 2010; 59: 901-908.
57. Laurell AC, Herrera JR.WHOand pandemic flu. What happened in Mexico. Br Med J 2010; 340:c3465.
58. Zarocostas J. Confusion and delays beset WHO's management of H1N1 pandemic. Br Med J 2010; 341:c5534.
59. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-1944.
60. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. J Am Med Assoc 2009; 302:1872-1879.
61. Alizon S, Luciani F, Regoes RR. Epidemiological and clinical consequences of within-host evolution. Trends Microbiol 2010 [Epub ahead of print].
62. Kotsimbos T, Waterer G, Jenkins C, et al. Influenza A/H1N1-09: Australia and New Zealand's winter of discontent. Am J Respir Crit Care Med 2010; 181:300-306.
63. World Health Organisation. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006; 12:88-94.
64. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361:1767-1772. (Pubitemid 36638424)
65. Maunder RG, Leszcz M, Savage D, et al. Applying the lessons of SARS to pandemic influenza: an evidence-based approach to mitigating the stress experienced by healthcare workers. Can J Public Health 2008; 99:486-488.
66. Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361:1519-1520. (Pubitemid 36566344)
67. Tan CC. SARS in Singapore: key lessons from an epidemic. Ann Acad Med Singapore 2006; 35:345-349.
68. Halder N, Kelso JK, Milne GJ. Developing guidelines for school closure interventions to be used during a future influenza pandemic. BMC Infect Dis 2010; 10:221.
69. Waterer GW, Hui DS, Jenkins CR. Public health management of pandemic (H1N1) 2009 infection in Australia: a failure! Respirology 2010; 15:51-56.
70. Randolph W, Viswanath K. Lessons learned from public health mass media campaigns: marketing health in a crowded media world. Annu Rev Public Health 2004; 25:419-437. (Pubitemid 38543625)
71. Kelso JK, Halder N, Milne GJ. The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009. PLoS One 2010; 5:e13797.
72. Reddy D. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. J Antimicrob Chemother 2010; 65 (Suppl 2):ii35-ii40.
73. Lo JY, Tsang TH, Leung YH, et al. Respiratory infections during SARS outbreak Hong Kong, 2003. Emerg Infect Dis 2005; 11:1738-1741.
74. Park JH, Cheong HK, Son DY, et al. Perceptions and behaviors related to hand hygiene for the prevention of H1N1 influenza transmission among Korean university students during the peak pandemic period. BMC Infect Dis 2010; 10:222.
75. Lau JT, Tsui HY, Kim JH, et al. Monitoring of perceptions, anticipated behavioral, and psychological responses related to H5N1 influenza. Infection 2010; 38:275-283.
76. Wong LP, Sam IC. Behavioral responses to the influenza A(H1N1) outbreak in Malaysia. J Behav Med 2010 [Epub ahead of print].
77. Van D, McLaws ML, Crimmins J, et al. University life and pandemic influenza: attitudes and intended behaviour of staff and students towards pandemic (H1N1) 2009. BMC Public Health 2010; 10:130.
78. Greenberg ME, Lai MH, Hartel GF, et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine: preliminary report. N Engl J Med 2009; 361:2405-2413.
79. Woodland DL. Progress towards a SARS vaccine. Viral Immunol 2010; 23:455.
80. Bone A, Guthmann JP, Nicolau J, Levy-Bruhl D. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine 2010; 28:8157-8161.
81. Maurer J, Uscher-Pines L, Harris KM. Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter? PrevMed 2010; 51:185-187.
82. Seale H, Heywood AE, McLaws ML, et al. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis 2010; 10:99.
83. Rambhia KJ, Watson M, Sell TK, et al. Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations. Biosecur Bioterror 2010; 8:321-330.
84. Hessel L. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges. Influenza Other Respir Viruses 2009; 3:165-170.
85. Enserink M. Swine flu pandemic. Developing countries to get some H1N1 vaccine: but when? Science 2009; 326:782.